Angitia Biopharmaceuticals
This role involves leading the identification, characterization, and optimization of animal disease models while conducting in vivo studies to support drug development programs. The position requires independent execution of cell-based research, molecular biology assays, and histopathological analysis to evaluate efficacy and mechanisms of action. The incumbent will also mentor junior team members, ensure experimental compliance, and facilitate cross-functional collaboration within the R&D pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Angitia Biopharmaceuticals.
Angitia Biopharmaceuticals didn’t post a salary, so this is our estimate from similar listings.